Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression

Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression

Malignant salivary gland tumors form 11% of all head and neck tumors. Salivary duct carcinoma (SDC) of the parotid gland is an uncommon and highly aggressive tumor accounting for 2% of all salivary gland malignancies. The fourth edition of the WHO Classification of Head and Neck Tumors reported glob...

Full description

Bibliographic Details
Main Authors: Jelena Berendika, Saša Jungić, Biljana Tubić, Gordana Malčić Kecman, Ivanka Rakita, Zdenka Gojković, Milka Vještica, Gordan Nikić, Božana Babić
Format: Article
Language:English
Published: Karger Publishers 2021-03-01
Series:Case Reports in Oncology
Subjects:
salivary duct carcinoma
adjuvant therapy
trastuzumab
Online Access:https://www.karger.com/Article/FullText/514850

Internet

https://www.karger.com/Article/FullText/514850

Similar Items